WordNet

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 慢性血栓塞栓性肺高血圧症の臨床症状および診断 clinical manifestations and diagnosis of chronic thromboembolic pulmonary hypertension
2. 成人における肺静脈閉塞症の疫学、病因、臨床評価および診断 epidemiology pathogenesis clinical evaluation and diagnosis of pulmonary veno occlusive disease in adults
3. 急性肺塞栓症の疑いがある妊娠していない成人女性の臨床症状、評価、診断 clinical presentation evaluation and diagnosis of the nonpregnant adult with suspected acute pulmonary embolism
4. 成人の肺腫瘍塞栓症および癌性リンパ管症：疫学、病因、発症機序 pulmonary tumor embolism and lymphangitic carcinomatosis in adults epidemiology etiology and pathogenesis
5. 急性肺塞栓症および下肢深部静脈血栓症における線溶（血栓溶解）療法 fibrinolytic thrombolytic therapy in acute pulmonary embolism and lower extremity deep vein thrombosis

Lewis NC1, Smith KJ1, Bain AR1, Wildfong KW1, Numan T2, Ainslie PN1.
Clinical science (London, England : 1979).Clin Sci (Lond).2015 Jul 1;129(2):169-78. doi: 10.1042/CS20140751.
We examined the impact of progressive hypotension with and without hypocapnia on regional extracranial cerebral blood flow (CBF) and intracranial velocities. Participants underwent progressive lower-body negative pressure (LBNP) until pre-syncope to inflict hypotension. End-tidal carbon dioxide was
PMID 25697830

Ex vivo non-invasive assessment of cell viability and proliferation in bio-engineered whole organ constructs.

Ren X1, Tapias LF2, Jank BJ1, Mathisen DJ2, Lanuti M2, Ott HC3.
Biomaterials.Biomaterials.2015 Jun;52:103-12. doi: 10.1016/j.biomaterials.2015.01.061. Epub 2015 Feb 21.
Decellularized organ scaffolds allow whole organ regeneration and study of cell behavior in three-dimensional culture conditions. Cell viability within the bio-engineered organ constructs is an essential parameter reflecting the performance of participating cells during long-term ex vivo culture, a
PMID 25818417

Design and validation of a clinical-scale bioreactor for long-term isolated lung culture.

Charest JM1, Okamoto T1, Kitano K1, Yasuda A1, Gilpin SE2, Mathisen DJ1, Ott HC3.
Biomaterials.Biomaterials.2015 Jun;52:79-87. doi: 10.1016/j.biomaterials.2015.02.016. Epub 2015 Feb 23.
The primary treatment for end-stage lung disease is lung transplantation. However, donor organ shortage remains a major barrier for many patients. In recent years, techniques for maintaining lungs ex vivo for evaluation and short-term (<12 h) resuscitation have come into more widespread use in
PMID 25818415